Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, ALS expert Terry Heiman-Patterson, MD, discusses best practices for ALS diagnosis and use of targeted therapy. Learning Objectives Upon successful...

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, ALS expert clinician-researcher Richard Bedlack MD, PhD, discusses targeted therapy for ALS and the role of individualized, multidisciplinary care to...

This video-based program is designed to provide education on identifying hypercortisolism using a unique format in which the potential consequences of a delayed diagnosis will be revealed using patient-clinician interaction videos. The faculty will focus on recognizing subclinical or atypical...

This online activity is designed to update clinicians on data presented at the American Society of Retina Specialists 43rd Annual Meeting held in Long Beach, CA, from July 30 to August 2, 2025. Expert thought leaders provide insights to help...

This online, on-demand virtual symposium brings together renowned experts in neurotrophic keratitis (NK). In this educational program, these experts discuss the symptoms associated with NK, present video demonstrations of various techniques for corneal sensitivity testing, and share their perspectives and...

Review of data presented at recent conferences on newer therapies for neovascular age-related macular degeneration and diabetic macular edema. This online activity is designed to update clinicians on data presented at meetings of retina specialists; these include the Retina World...

Given its complex presentation, Gaucher disease—a rare lysosomal storage disease with varying consequences across its subtypes—is frequently misdiagnosed or diagnosed with delay. In this program, a hematologist provides an overview of recent guidelines and expert recommendations on the diagnosis of...

Despite growing awareness of the role of newer anti-VEGF agents in the management of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), retina specialists may still face challenges in extending patients’ treatment intervals with...

This Burst CME features an expert-led video discussion on TL1A pathophysiology, which has led to a promising new class of biologics for moderate-to-severe IBD with potential to transform care by addressing both inflammatory and fibrostenotic complications. Emerging evidence on TL1A...

Despite growing awareness of the role of newer anti-VEGF agents in the management of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), retina specialists may still face challenges in extending patients’ treatment intervals with...